GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:February 4, 2018 Post category:BioPharma Companies including Sanofi, J&J, Nestle have dropped out. Source: BioSpace You Might Also Like Tauriga Secures Investment Of $80,000 USD Through A 5% Promissory Note With Fixed Conversion Price Of $0.00125 Per Share June 29, 2017 FDA Just Rejected Eli Lilly, Incyte's Rheumatoid Arthritis Drug Baricitinib April 13, 2017 Editas CEO to Testify at a U.S. Senate Hearing Next Week November 7, 2017
Tauriga Secures Investment Of $80,000 USD Through A 5% Promissory Note With Fixed Conversion Price Of $0.00125 Per Share June 29, 2017
